These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 244933)

  • 1. Dopamine and schizophrenia.
    Owens DG
    Nurs Mirror; 1978 Feb; 146(5):23-6. PubMed ID: 244933
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and schizophrenia.
    Ashby B
    Nature; 1990 Dec; 348(6301):493. PubMed ID: 2174127
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine, serotonin, and schizophrenia.
    van Veelen NM; Kahn RS
    Adv Neurol; 1999; 80():425-9. PubMed ID: 10410751
    [No Abstract]   [Full Text] [Related]  

  • 4. [Only the dopamine hypothesis in schizophrenia?].
    Valchár M
    Cesk Psychiatr; 1987 Apr; 83(2):98-104. PubMed ID: 3581265
    [No Abstract]   [Full Text] [Related]  

  • 5. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review.
    Sayed Y; Garrison JM
    Psychopharmacol Bull; 1983; 19(2):283-8. PubMed ID: 6135238
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for schizophrenia--all roads lead to dopamine.
    Di Forti M; Lappin JM; Murray RM
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine hypothesis: variations on a theme (II).
    Wyatt RJ
    Psychopharmacol Bull; 1986; 22(3):923-7. PubMed ID: 3797593
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
    Meltzer HY
    Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of dopaminergic function in schizophrenia [proceedings].
    Angrist B; Rotrosen J; Gershon S
    Psychopharmacol Bull; 1980 Jan; 16(1):59-60. PubMed ID: 7360844
    [No Abstract]   [Full Text] [Related]  

  • 10. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
    Benes FM
    Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
    [No Abstract]   [Full Text] [Related]  

  • 11. Is elevated striatal dopamine function a prodromal sign of schizophrenia?
    Simon AE; Umbricht D
    Arch Gen Psychiatry; 2009 Aug; 66(8):916-7. PubMed ID: 19652133
    [No Abstract]   [Full Text] [Related]  

  • 12. Gaba blockade, dopamine and schizophrenia: experimental activation of the mesolimbic system.
    Stevens JR
    Int J Neurol; 1975; 10(1-4):115-27. PubMed ID: 1237474
    [No Abstract]   [Full Text] [Related]  

  • 13. Adaptation of the dopaminergic system in the pathophysiology and treatment of schizophrenia. Introduction.
    Friedhoff AJ
    Psychopharmacol Bull; 1988; 24(3):335-7. PubMed ID: 3153489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopaminergic receptor activity and the evolution of schizophrenia].
    Fodoreanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine and CNV: studies of drugs, disease and nutrition.
    Tecce JJ
    Electroencephalogr Clin Neurophysiol Suppl; 1991; 42():153-64. PubMed ID: 1680669
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic balance and subtypes of schizophrenia.
    Dávila R; Zumárraga M; Andia I; Manero E; Retuerto F; Barcena B; Guimón J
    Br J Psychiatry Suppl; 1989 May; (4):57-60. PubMed ID: 2690881
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and DA-hypothesis: pathological and therapeutic aspects. 9th annual meeting of the Belgian College of Neuropsychopharmacological and Biological Psychiatry. Louvain-en-Woluwe, 21 November 1986. Proceedings.
    Acta Psychiatr Belg; 1987; 87(5):521-617. PubMed ID: 3451673
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine assessment of dopaminergic activity in schizophrenia.
    Rotrosen J; Angrist BM; Gershon S; Sachar EJ; Halpern FS
    Adv Biochem Psychopharmacol; 1977; 16():649-53. PubMed ID: 883563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Schizophrenia and dopaminergic modulation. Diagnostic and therapeutic implications].
    Péron-Magnan P; Ginestet D
    Encephale; 1989; 15 Spec No():181-91. PubMed ID: 2663445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.